Home LiteratureArticle Details
PMID: 12556242 Published · epublish English Journal Article Research Support, Non-U.S. Gov't Review

The relationship between diabetes and pancreatic cancer.

Molecular cancer ·Vol. 2 ·2003-01-06 ·Pages 4

Wang F, Herrington M, Larsson J, Permert J

Abstract

About 80% of pancreatic cancer patients have glucose intolerance or frank diabetes. This observation has led to the following two hypotheses: i. pancreatic cancer causes the associated diabetes and ii. the conditions associated with diabetes promote the development of pancreatic cancer. Evidence supporting both hypotheses has been accumulated in previous studies. This article reviews these studies, especially those that have been conducted recently.

MeSH Terms
Animals Diabetes Mellitus/etiology Humans Pancreatic Neoplasms/complications
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wang Feng
Surgery Department, Karolinska Institute at Huddinge University Hospital, 141 86 Stockholm, Sweden. feng.wang@cfss.ki.se
Herrington Margery
Larsson Jörgen
Permert Johan
References (60)
60 references, click to expand
  1. The intracellular mechanism of insulin resistance in pancreatic cancer patients.
    J Clin Endocrinol Metab. 2000 Mar;85(3):1232-8 PMID: 10720068
  2. The intracellular mechanism of insulin resistance in the hamster pancreatic ductal adenocarcinoma model.
    Pancreas. 1998 Nov;17(4):359-66 PMID: 9821177
  3. Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells.
    Pancreas. 1999 May;18(4):403-9 PMID: 10231847
  4. Diabetes and the risk of pancreatic cancer.
    Ann Oncol. 1999;10 Suppl 4:79-81 PMID: 10436791
  5. Cancer and diabetes--a follow-up study of two population-based cohorts of diabetic patients.
    J Intern Med. 1997 Jun;241(6):471-5 PMID: 10497622
  6. The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice.
    Anticancer Res. 1995 Nov-Dec;15(6B):2585-8 PMID: 8669828
  7. Abnormal glucose metabolism and pancreatic cancer mortality.
    JAMA. 2000 May 17;283(19):2552-8 PMID: 10815119
  8. Pancreatic cancer and diabetes: is there a relationship? A case-controlled study.
    Aust N Z J Surg. 2000 Oct;70(10):722-4 PMID: 11021485
  9. Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression.
    Pancreas. 2000 Oct;21(3):310-20 PMID: 11039477
  10. Risk factors for pancreatic cancer: a case-control study based on direct interviews.
    Teratog Carcinog Mutagen. 2001;21(1):7-25 PMID: 11135318
  11. Early changes in islet hormone secretion in the hamster pancreatic cancer model.
    Teratog Carcinog Mutagen. 2001;21(1):59-67 PMID: 11135321
  12. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.
    Cell. 2001 Feb 23;104(4):517-29 PMID: 11239409
  13. Do early symptoms of pancreatic cancer exist that can allow an earlier diagnosis?
    Pancreas. 2001 Mar;22(2):210-3 PMID: 11249079
  14. Prevention of pancreatic cancer induction in hamsters by metformin.
    Gastroenterology. 2001 Apr;120(5):1263-70 PMID: 11266389
  15. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer.
    Gastroenterology. 2001 Sep;121(3):640-5 PMID: 11522748
  16. In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
    Metabolism. 2001 Sep;50(9):1036-42 PMID: 11555835
  17. Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide.
    Pancreas. 2002 Jan;24(1):8-14 PMID: 11741177
  18. Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients.
    Pancreas. 2003 Mar;26(2):173-7 PMID: 12604916
  19. A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma.
    Am J Dig Dis. 1978 Dec;23(12):1107-14 PMID: 367155
  20. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.
    J Clin Invest. 1983 Jun;71(6):1544-53 PMID: 6134752
  21. Modification of pancreatic carcinogenesis in the hamster model. VIII. Inhibitory effect of exogenous insulin.
    J Natl Cancer Inst. 1984 May;72(5):1205-8 PMID: 6371345
  22. Carcinoma of the head of the pancreas. Therapeutic implications of endoscopic retrograde cholangiopancreatography findings.
    Gastroenterology. 1984 Jul;87(1):37-43 PMID: 6202585
  23. Insulin, via its own receptor, regulates growth and amylase synthesis in pancreatic acinar AR42J cells.
    Diabetes. 1985 Sep;34(9):891-7 PMID: 2411617
  24. Pancreatic insulin secretion in exocrine pancreatic cancer.
    J Surg Res. 1986 Jun;40(6):588-96 PMID: 3528667
  25. Abnormal insulin secretion in carcinoma of the pancreas: response to glucagon stimulation.
    Diabet Med. 1985 Mar;2(2):113-6 PMID: 2952394
  26. Influence of diabetes on susceptibility to experimental pancreatic cancer.
    Am J Surg. 1988 Jan;155(1):159-64 PMID: 2963553
  27. Cancer of the pancreas. 50 years of surgery.
    Cancer. 1987 Nov 1;60(9):2284-303 PMID: 3326653
  28. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin.
    Cancer Res. 1990 Mar 1;50(5):1634-9 PMID: 2154330
  29. Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2.
    Gastroenterology. 1990 Jun;98(6):1666-74 PMID: 2186957
  30. Expression of and response to growth regulatory peptides by two human pancreatic carcinoma cell lines.
    Pancreas. 1990 Jul;5(4):369-80 PMID: 2199964
  31. Insulin therapy prevents spontaneous recovery from streptozotocin-induced diabetes in Syrian hamsters. An autoradiographic and immunohistochemical study.
    Virchows Arch A Pathol Anat Histopathol. 1990;417(4):333-41 PMID: 2146799
  32. Insulin secretion and action in patients with pancreatic cancer.
    Cancer. 1991 Jan 15;67(2):486-93 PMID: 1985741
  33. Effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines.
    J Cancer Res Clin Oncol. 1991;117(5):416-20 PMID: 1679759
  34. Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor?
    Am J Surg. 1993 Jan;165(1):61-6; discussion 66-7 PMID: 8380314
  35. Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster.
    Res Exp Med (Berl). 1993;193(1):21-6 PMID: 8446769
  36. Pancreatic cancer is associated with impaired glucose metabolism.
    Eur J Surg. 1993 Feb;159(2):101-7 PMID: 8098623
  37. Effect of streptozotocin diabetes on development of nitrosamine-induced pancreatic carcinoma when diabetes induction occurs after nitrosamine exposure.
    Carcinogenesis. 1993 May;14(5):961-7 PMID: 8504490
  38. Endocrine aspects of exocrine cancer of the pancreas. Their patterns and suggested biologic significance.
    Am J Clin Pathol. 1993 Sep;100(3):223-30 PMID: 8379530
  39. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
    N Engl J Med. 1994 Feb 3;330(5):313-8 PMID: 8277951
  40. Diabetes and the risk of pancreatic cancer.
    N Engl J Med. 1994 Jul 14;331(2):81-4 PMID: 8208269
  41. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.
    JAMA. 1995 May 24-31;273(20):1605-9 PMID: 7745774
  42. GI hormonal changes in diabetes influence pancreatic cancer growth.
    J Surg Res. 1995 Jun;58(6):754-8 PMID: 7791356
  43. Reversal of enhanced pancreatic cancer growth in diabetes by insulin.
    Surgery. 1995 Aug;118(2):453-7; discussion 457-8 PMID: 7638764
  44. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden.
    J Natl Cancer Inst. 1995 Jun 21;87(12):930-1 PMID: 7666483
  45. The role of pancreatic islets in experimental pancreatic carcinogenicity.
    Am J Pathol. 1995 Nov;147(5):1456-64 PMID: 7485408
  46. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors.
    J Surg Res. 1996 Jun;63(1):310-3 PMID: 8661216
  47. Experimental evidence for the origin of ductal-type adenocarcinoma from the islets of Langerhans.
    Am J Pathol. 1997 Jun;150(6):2167-80 PMID: 9176407
  48. Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines.
    Int J Pancreatol. 1997 Apr;21(2):157-64 PMID: 9209957
  49. Islet hormone secretion in pancreatic cancer patients with diabetes.
    Pancreas. 1997 Jul;15(1):60-8 PMID: 9211494
  50. Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia.
    Int J Cancer. 1997 Aug 7;72(4):637-41 PMID: 9259404
  51. An unidentified pancreatic cancer cell product alters some intracellular pathways of glucose metabolism in isolated rat hepatocytes.
    Pancreas. 1997 Aug;15(2):132-8 PMID: 9260197
  52. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.
    J Natl Cancer Inst. 1997 Sep 17;89(18):1360-5 PMID: 9308706
  53. Chronic low dose islet amyloid polypeptide infusion reduces food intake, but does not influence glucose metabolism, in unrestrained conscious rats: studies using a novel aortic catheterization technique.
    Endocrinology. 1997 Oct;138(10):4081-5 PMID: 9322915
  54. The effect of streptozotocin and a high-fat diet on BOP-induced tumors in the pancreas and in the submandibular gland of hamsters bearing transplants of homologous islets.
    Cancer Lett. 1997 Aug 19;117(2):155-60 PMID: 9377543
  55. Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin.
    Gastroenterology. 1998 Jan;114(1):130-8 PMID: 9428227
  56. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse.
    Surgery. 1998 Mar;123(3):315-20 PMID: 9526524
  57. In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets.
    J Surg Res. 1998 Sep;79(1):13-9 PMID: 9735234
  58. Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer.
    Cancer Res. 1998 Oct 1;58(19):4250-4 PMID: 9766646
  59. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults.
    Cancer Causes Control. 1998 Aug;9(4):403-10 PMID: 9794172
  60. Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets.
    Am J Physiol. 1999 Jan;276(1 Pt 1):E19-24 PMID: 9886946
Article Info
Journal
Molecular cancer
Abbr.
Mol Cancer
ISSN
1476-4598
DOI
10.1186/1476-4598-2-4
Email
feng.wang@cfss.ki.se
Published
2003-01-06
Epub
2003-00-06
Pages
4
Language
English
Region
England
NLM ID
101147698
PMCID
PMC149418
Subset
IM
External Links
PubMed source DOI: 10.1186/1476-4598-2-4 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2